 |
112 Diseases |  |
125 Trials |
|
125 Trials |  |
6082 News |  |
| «12...53545556575859606162636465 |
- | Victoza (liraglutide) / Novo Nordisk
New P1 trial: Comparison of Three Liraglutide Formulations in Healthy Volunteers (clinicaltrials.gov) - Jan 16, 2012
P1, N=24, Completed, Sponsor: Novo Nordisk
- | Victoza (liraglutide) / Novo Nordisk
New P1 trial: Comparison of Liraglutide Inhaled Into the Lungs Compared to Liraglutide Injected Under the Skin in Healthy Male Volunteers (clinicaltrials.gov) - Jan 16, 2012
P1, N=32, Completed, Sponsor: Novo Nordisk
- | Victoza (liraglutide) / Novo Nordisk
New P1 trial: Comparison of Liraglutide Injected at Three Different Injection Sites in Healthy Volunteers (clinicaltrials.gov) - Jan 15, 2012
P1, N=21, Completed, Sponsor: Novo Nordisk
- ||||| Victoza (liraglutide) / Novo Nordisk
New P2 trial, Monotherapy: Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent (clinicaltrials.gov) - Jan 11, 2012
P2, N=223, Completed, Sponsor: Novo Nordisk
- | Victoza (liraglutide) / Novo Nordisk
New P1 trial: Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group (clinicaltrials.gov) - Jan 11, 2012
P1, N=20, Completed, Sponsor: Novo Nordisk
- | Victoza (liraglutide) / Novo Nordisk
New P1 trial: Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 Diabetes (clinicaltrials.gov) - Jan 11, 2012
P1, N=19, Completed, Sponsor: Novo Nordisk
- | Victoza (liraglutide) / Novo Nordisk
New P2 trial: Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diabetes (clinicaltrials.gov) - Jan 8, 2012
P2, N=35, Completed, Sponsor: Novo Nordisk
- | Victoza (liraglutide) / Novo Nordisk
New P2 trial: Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes (clinicaltrials.gov) - Jan 8, 2012
P2, N=17, Completed, Sponsor: Novo Nordisk
- | Victoza (liraglutide) / Novo Nordisk
New P1 trial: Comparison of Two Liraglutide Formulations in Healthy Volunteers (clinicaltrials.gov) - Jan 8, 2012
P1, N=22, Completed, Sponsor: Novo Nordisk
- | Victoza (liraglutide) / Novo Nordisk
New P1 trial: Influence on the Effect of an Oral Contraceptive Drug After Administration of Liraglutide in Postmenopausal Women (clinicaltrials.gov) - Jan 8, 2012
P1, N=21, Completed, Sponsor: Novo Nordisk
- | Victoza (liraglutide) / Novo Nordisk
New P1 trial: Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function (clinicaltrials.gov) - Jan 8, 2012
P1, N=30, Completed, Sponsor: Novo Nordisk
- Victoza (liraglutide) / Novo Nordisk
New P1 trial: Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver Function (clinicaltrials.gov) - Jan 8, 2012
P1, N=24, Completed, Sponsor: Novo Nordisk A/S
- | Victoza (liraglutide) / Novo Nordisk
New P1 trial: Safety and Tolerability of Liraglutide in Healthy Volunteers and Subjects With Type 2 Diabetes (clinicaltrials.gov) - Jan 8, 2012
P1, N=24, Completed, Sponsor: Novo Nordisk
- Victoza (liraglutide) / Novo Nordisk
New P1 trial: Safety and Tolerability of Liraglutide in Healthy Male Volunteers (clinicaltrials.gov) - Jan 8, 2012
P1, N=34, Completed, Sponsor: Novo Nordisk A/S
- ||||| Victoza (liraglutide) / Novo Nordisk
New P2 trial: Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes (clinicaltrials.gov) - Jan 5, 2012
P2, N=196, Completed, Sponsor: Novo Nordisk
- | Victoza (liraglutide) / Novo Nordisk
New P1 trial: Comparison of the Effect of Liraglutide in Young Versus Elderly Healthy Volunteers (clinicaltrials.gov) - Jan 5, 2012
P1, N=32, Completed, Sponsor: Novo Nordisk
- | Victoza (liraglutide) / Novo Nordisk
New P1 trial: Effect of Liraglutide on Pulsatile Insulin Secretion in Subjects With Type 2 Diabetes (clinicaltrials.gov) - Jan 5, 2012
P1, N=11, Completed, Sponsor: Novo Nordisk
- ||||| Victoza (liraglutide) / Novo Nordisk
New P4 trial: Adding Liraglutide to High Dose Insulin: Breaking the Cycle (clinicaltrials.gov) - Jan 4, 2012
P4, N=80, Recruiting, Sponsor: Ildiko Lingvay
- | Victoza (liraglutide) / Novo Nordisk
New P4 trial: Time Course of the Blood Pressure Lowering Effect of Liraglutide Therapy in Type 2 Diabetes (clinicaltrials.gov) - Dec 22, 2011
P4, N=35, Enrolling by invitation, Sponsor: Peter Rossing
- Victoza (liraglutide) / Novo Nordisk
New P2 trial: The role of gut hormones replacement in improving blood flow to the brain after stroke that affects swallowing. (EUDRACT) - Dec 5, 2011
P2, N=40, Ongoing, Sponsor: Royal Devon & Exeter NHS Foundation Trust`University of Exeter
- | Victoza (liraglutide) / Novo Nordisk
Trial completion: Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222) (clinicaltrials.gov) - Dec 5, 2011
P1, N=12, Completed, Sponsor: Merck Sharp & Dohme Corp.
Active, not recruiting --> Completed
- Victoza (liraglutide) / Novo Nordisk
New P4 trial, Surgery, Bariatric surgery: Treatment of patients with Liraglutide prior to bariatric sugery (EUDRACT) - Nov 9, 2011
P4, N=46, Ongoing, Sponsor: University Medical Center Hamburg-Eppendorf
- | Victoza (liraglutide) / Novo Nordisk
Enrollment closed: Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE (clinicaltrials.gov) - Oct 24, 2011
P3, N=3733, Active, not recruiting, Sponsor: Novo Nordisk A/S
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Victoza (liraglutide) / Novo Nordisk
New P4 trial: The Effects of Physical Training and GLP-1 Receptor Agonist Liraglutide Treatment in Patients With Type 2 Diabetes (clinicaltrials.gov) - Oct 18, 2011
P4, N=40, Active, not recruiting, Sponsor: Tina Vilsboll
- Victoza (liraglutide) / Novo Nordisk
New P3 trial, Surgery: Controlling Glucose during Elective hip Surgery to study the influence on Coagulation (EUDRACT) - Oct 18, 2011
P3, N=36, Ongoing, Sponsor: AMC, Amsterdam
- Victoza (liraglutide) / Novo Nordisk
Enrollment change: GLP-1 Receptors in Normal Skin and Skin From Patients With Psoriasis (clinicaltrials.gov) - Oct 10, 2011
P=N/A, N=12, Recruiting, Sponsor: University Hospital, Gentofte, Copenhagen
Recruiting --> Active, not recruiting N=20 --> 12
- Victoza (liraglutide) / Novo Nordisk
Clinical: GLP-1 Receptors in Normal Skin and Skin From Patients With Psoriasis (clinicaltrials.gov) - Oct 10, 2011
P=N/A, N=12, Recruiting, Sponsor: University Hospital, Gentofte, Copenhagen
- | Victoza (liraglutide) / Novo Nordisk
Trial completion: Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes (clinicaltrials.gov) - Oct 2, 2011
P1, N=21, Completed, Sponsor: Novo Nordisk
N=20 --> 12 Active, not recruiting --> Completed
- ||||||| Tanzeum (albiglutide) / GSK
Trial completion: A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide. (clinicaltrials.gov) - Sep 21, 2011
P3, N=841, Completed, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Victoza (liraglutide) / Novo Nordisk
New P2 trial, Combination therapy: Liraglutide and Heart Failure in Type 2 Diabetes (clinicaltrials.gov) - Aug 28, 2011
P2, N=80, Recruiting, Sponsor: Thomas Nystrom
- | Victoza (liraglutide) / Novo Nordisk
New P4 trial: Does the GLP-1 like-hormone (Victoza (EUDRACT) - Aug 25, 2011
P4, N=60, Ongoing, Sponsor: Dr. med. Tina Vilsb
- |||||| Victoza (liraglutide) / Novo Nordisk
Enrollment open, Monotherapy: Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM) (clinicaltrials.gov) - Aug 24, 2011
P3, N=150, Recruiting, Sponsor: BC Women's Hospital & Health Centre
Active, not recruiting --> Completed Not yet recruiting --> Recruiting